Ramon Cacabelos
Overview
Explore the profile of Ramon Cacabelos including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
114
Citations
1654
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Cacabelos R
Cent Nerv Syst Agents Med Chem
. 2025 Jan;
25(1):1-2.
PMID: 39882708
No abstract available.
2.
Cacabelos R, Martinez-Iglesias O, Cacabelos N, Carrera J, Rodriguez D, Naidoo V
Expert Opin Drug Metab Toxicol
. 2025 Jan;
1-28.
PMID: 39835706
Introduction: Genetic load influences the therapeutic response to conventional drugs in Alzheimer's disease (AD). Pharmacogenetics (PGx) is the best option to reduce drug-drug interactions and adverse drug reactions in patients...
3.
Cacabelos R
Life (Basel)
. 2025 Jan;
14(12.
PMID: 39768343
Over the past 25 years, pharmaceutical sciences have witnessed numerous groundbreaking discoveries that have transformed medical practice, improved patient outcomes, and expanded our understanding of disease mechanisms [...].
4.
Cacabelos R, Martinez-Iglesias O, Cacabelos N, Carrera I, Corzo L, Naidoo V
Life (Basel)
. 2025 Jan;
14(12.
PMID: 39768263
Alzheimer's disease (AD) is a complex/multifactorial brain disorder involving hundreds of defective genes, epigenetic aberrations, cerebrovascular alterations, and environmental risk factors. The onset of the neurodegenerative process is triggered decades...
5.
Cacabelos R
Cent Nerv Syst Agents Med Chem
. 2024 May;
24(1):1.
PMID: 38807474
No abstract available.
6.
Cacabelos R
Int J Mol Sci
. 2024 Apr;
25(7).
PMID: 38612479
Several historic, scientific events have occurred in the decade 2013-2023, in particular the COVID-19 pandemic. This massive pathogenic threat, which has affected the world's population, has had a devastating effect...
7.
8.
Carrera I, Corzo L, Martinez-Iglesias O, Naidoo V, Cacabelos R
Pharmaceuticals (Basel)
. 2023 Sep;
16(9).
PMID: 37765114
Neurodegeneration, characterized by the progressive deterioration of neurons and glial cells, is a feature of Alzheimer's disease (AD). The present study aims to demonstrate that the onset and early progression...
9.
Martinez-Iglesias O, Naidoo V, Carrera I, Carril J, Cacabelos N, Cacabelos R
Biology (Basel)
. 2023 Sep;
12(9).
PMID: 37759556
Pharmacogenetics and DNA methylation influence therapeutic outcomes and provide insights into potential therapeutic targets for brain-related disorders. To understand the effect of genetic polymorphisms on drug response and disease risk,...
10.
Martinez-Iglesias O, Naidoo V, Corzo L, Carrera I, Seoane S, Rodriguez S, et al.
Biology (Basel)
. 2023 Jun;
12(6).
PMID: 37372091
Dyslipidemia is a significant risk factor for cardiovascular disease and stroke. Our recent findings showed that RCI-1502, a bioproduct derived from the muscle of the European S. pilchardus, has lipid-lowering...